Frailty is an independent predictor of number and length of hospitalizationsin patients with fibrotic ILD

S. Guler (Vancouver, Canada), J. Kwan (Vancouver, Canada), P. Wilcox (Vancouver, Canada), C. Ryerson (Vancouver, Canada)

Source: International Congress 2018 – What is new in idiopathic interstitial pneumonias?
Session: What is new in idiopathic interstitial pneumonias?
Session type: Poster Discussion
Number: 5244
Disease area: Interstitial lung diseases

Congress or journal article abstractWebcastSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Guler (Vancouver, Canada), J. Kwan (Vancouver, Canada), P. Wilcox (Vancouver, Canada), C. Ryerson (Vancouver, Canada). Frailty is an independent predictor of number and length of hospitalizationsin patients with fibrotic ILD. 5244

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
SADL scale as a predictor of mortality in patients with ILD associated with Scleroderma
Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases
Year: 2021


Automatic quantitative fibrosis scores at baseline is a predictor of progression in patients with IPF
Source: International Congress 2017 – Idiopathic pulmonary fibrosis (IPF): clinical problems
Year: 2017

6MWT as useful predictor for long term survival after lung transplantation in patients with ILD
Source: Virtual Congress 2020 – Clinical management of lung transplant recipients
Year: 2020

Validation of bode index as a predictor of mortality in COPD patients
Source: Annual Congress 2008 - Prognosis in COPD
Year: 2008

6-minute walk distance is an independent predictor of mortality in patients with idiopathic pulmonary fibrosis
Source: Eur Respir J 2014; 43: 1421-1429
Year: 2014



Rheumatoid arthritis-related interstitial lung disease (RA-ILD): Clinical, functional features, and variables associated poor initial prognosis in a chilean cohort
Source: Virtual Congress 2020 – Clinical aspects and new treatment strategies for rare interstitial lung diseases in adults and children
Year: 2020

BODE index as predictor of exacerbation occurrence in ambulatory patients with COPD
Source: Annual Congress 2007 - Exacerbations of COPD
Year: 2007


Walking distance is a predictor of exacerbations in patients with COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 633s
Year: 2004

Do worse scores on patient-reported outcomes predict the progression of interstitial lung disease (ILD)?
Source: Virtual Congress 2021 – Interstitial lung disease around the world
Year: 2021


Assessment of severity and prognosis in COPD: moving beyond percent of predicted
Source: Eur Respir J, 52 (2) 1801005; 10.1183/13993003.01005-2018
Year: 2018



Sleep duration is an independent determinant of metabolic impairment in COPD patients
Source: International Congress 2018 – Nutrition and metabolic syndrome in COPD
Year: 2018


The association between functional and HRQOL (K-BILD) outcome measures in IPF and other fibrotic ILDs
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016


Weight loss as a predictor of mortality in patients with interstitial lung disease
Source: Eur Respir J, 52 (3) 1801289; 10.1183/13993003.01289-2018
Year: 2018



Male gender and fibrosis score on high-resolution computed tomography are independent poor prognostic factors of survival in patients with rheumatoid arthritis-related interstitial lung disease.
Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment
Year: 2017


Lung function reversibility as a predictor of disease progression in COPD
Source: International Congress 2017 – Markers of COPD progression
Year: 2017

Is age a predictor in prognosis of patients with idiopathic pulmonary fibrosis?
Source: Annual Congress 2008 - Management of idiopathic pulmonary fibrosis: what can we learn from the pathophysiology?
Year: 2008

Cardio-vascular co-morbidities and severity of lung function impairment in a COPD cohort
Source: Eur Respir J 2006; 28: Suppl. 50, 160s
Year: 2006

The eNose as a predictor of disease severity and treatment response
Source: International Congress 2015 – Individualised risk reduction strategies for patients with COPD
Year: 2015



Sarcopenia in Japanese patients with COPD: prevalence, relationship with COPD severity.
Source: International Congress 2017 – Extrapulmonary comorbidities in COPD
Year: 2017

Is COPD an independent predictor of osteoporosis?
Source: International Congress 2015 – COPD: notable points
Year: 2015